This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Citigroup, MedAssets: Analysts' New Ratings

Editor's Note: Green and red arrows refer to intraday stock price movement.


Adobe Systems (ADBE - Get Report) upgraded at UBS from Neutral to Buy, UBS said. $40 price target. Survey suggests that demand is stabilizing.

Citigroup (C - Get Report) downgraded at Goldman to Buy from Neutral, Goldman Sachs said. Company also removed from the Conviction List.

Cheesecake Factory (CAKE - Get Report) upgraded at Sterne Agee from Neutral to Buy, Sterne Agee said. $36 price target. Valuation call, following the recent pullback.

CBOE Holdings (CBOE - Get Report) upgraded at Credit Suisse to Outperform from Neutral. Strong fundamentals and more deals coming, Credit Suisse said. Price target raised to $32 from $25.

Copart (CPRT) rated new Buy at Goldman. $48 price target. Company can deliver consistent cash flow growth.

Coinstar (CSTR) downgraded at JP Morgan from Neutral to Underweight. $42 price target. Consensus estimates appear too high.

Fifth Third (FITB - Get Report) upgraded at FBR from Market Perform to Outperform, FBR Capital Markets said. $17 price target. Company has the most relative excess capital.

First Solar (FSLR - Get Report) estimates, target boosted at Goldman. Shares of FSLR now seen reaching $190, according to Goldman Sachs. Estimates also upped, given improved volume visibility. Buy rating.

First Solar (FSLR - Get Report) downgraded at UBS from Buy to Neutral, UBS said. Valuation call, based on a $180 price target.

Foster Wheeler (FWLT) downgraded at BB&T to Hold, BB&T Capital said. Company guided toward lower near-term margins.

Goldcorp (GG) upgraded at Deutsche to Buy, Deutsche Bank said. Company is seeing solid growth an boosted its dividend. $60 price target.

Hill-Rom (HRC) upgraded at Soleil from Accumulate to Buy, Soleil Securities said. Valuation call, based on a $54 price target. Hospital spending appears to be improving.

InterActiveCorp (IACI) rated new Hold at Canaccord. $28 price target. Stock is pricing in the potential for increased competition.

LDK Solar (LDK) rated new Buy at Kaufman. $24 price target. Stock trades at a significant discount to its peers.

MedAssets (MDAS) downgraded at Deutsche to Hold. $19 price target. Company has limited earnings visibility.

MedAssets downgraded at Piper to Underweight. $15 price target. Company is seeing lower growth across the board.

MedAssets downgraded at ThinkEquity from Buy to Hold, ThinkEquity said. $18 price target. Company slashed its forward guidance.

MedAssets downgraded at Citi from Buy to Hold on disappointing 4Q10 results, Citigroup said. Price target cut to $20 from $26.

MedAssets downgraded at Baird from Outperform to Neutral. $18 price target. Company lowered its earnings outlook.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
ADBE $73.85 -1.45%
CBOE $61.79 3.21%
C $37.51 -0.79%
CAKE $46.99 -0.59%
FWLT $27.52 -3.06%


Chart of I:DJI
DOW 16,014.38 -12.67 -0.08%
S&P 500 1,852.21 -1.23 -0.07%
NASDAQ 4,268.7630 -14.99 -0.35%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs